Doctor Hirotoshi Watanabe
Hirakata Kohsai Hospital, Hirakata (Japan)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Post-PCI anticoagulation with unfractionated heparin in acute coronary syndrome: insight from the STOPDAPT-3 trial
Event: ESC Congress 2024
Topic: Pharmacotherapy
Session: Tailored approaches to cardiovascular therapy in acute coronary syndromes
Clopidogrel following 1-month aspirin-free low-dose prasugrel monotherapy versus aspirin following 1-month DAPT after PCI for patients with ACS or HBR: Final 1-year results from the STOPDAPT-3
Event: ESC Congress 2024
Topic: Pharmacotherapy
Session: Trial updates and other studies on percutaneous coronary intervention
STOPDAPT-2 ACS: one-month dual antiplatelet therapy followed by clopidogrel monotherapy in acute coronary syndrome
Event: ESC Congress 2021 - The Digital Experience
Topic: Adjunctive Pharmacotherapy
Session: Hot Line - STOPDAPT-2 ACS
Post-discharge myocardial infarction after percutaneous coronary intervention: incidence, risk factors, size distribution and its prognostic significance
Event: ESC Congress 2017
Topic: PCI: long-term outcome
Session: PCI - Long-term outcome
